Compared to pre-intervention, after the intervention, both groups showed reductions in left ventricular end-diastolic diameter, N-terminal pro-b-type natriuretic peptide, cardiac troponin I levels, Self-Rating Anxiety Scale and Self-Rating Depression Scale scores, with an increase in left ventricular ejection fraction. The gene discussed is TNNI3; the disease is depressive disorder.